PSG9 Protein (AA 35-426) (His tag)

N° du produit ABIN1880612

Détail du produit

Antigène: PSG9 (Pregnancy Specific beta-1-Glycoprotein 9 (PSG9))

Type de proteíne: Recombinant

Attributs du protein: AA 35-426

Origine: Humain

Source: Human Cells

Purification/Conjugué: Cette PSG9 protéine est marqué à la His tag.

Fonction: Recombinant Human Pregnancy-Specific β-1-Glycoprotein 9/PSBG9 (C-6His)

Séquence: EVTIEAQPPK VSEGKDVLLL VHNLPQNLPG YFWYKGEMTD LYHYIISYIV DGKIIIYGPA YSGRETVYSN ASLLIQNVTR KDAGTYTLHI IKRGDETREE IRHFTFTLYL ETPKPYISSS NLNPREAMEA VRLICDPETL DASYLWWMNG QSLPVTHRLQ LSKTNRTLYL FGVTKYIAGP YECEIRNPVS ASRSDPVTLN LLPKLPIPYI TINNLNPREN KDVLAFTCEP KSENYTYIWW LNGQSLPVSP GVKRPIENRI LILPSVTRNE TGPYQCEIQD RYGGLRSNPV ILNVLYGPDL PRIYPSFTYY RSGENLDLSC FTESNPPAEY FWTINGKFQQ SGQKLFIPQI TRNHSGLYAC SVHNSATGKE ISKSMTVKVS GPCHGDLTES QSVDHHHHHH

Attributs du produit: Recombinant Human Pregnancy-specific beta-1-glycoprotein 9/PSG9/PSG11 is produced by our mammalian expression system in human cells. The target protein is expressed with sequence (Glu35-Ser426) of Human PSG9 fused with a polyhistidine tag at the C-terminus.

Pureté: > 95 % as determined by reducing SDS-PAGE.

Stérilité: 0.2 μm filtered

niveau d'endotoxine: Less than 0.1 ng/μg (1 IEU/μg) as determined by LAL test

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Reconstitution: It is not recommended to reconstitute to a concentration less than 100 μg/mL.
Dissolve the lyophilized protein in ddH2O.
Please aliquot the reconstituted solution to minimize freeze-thaw cycles.

Buffer: Supplied as a 0.2 μm filtered solution of 20 mM PB,150 mM NaCl, pH 7.5.

Conseil sur la manipulation: Always centrifuge tubes before opening. Do not mix by vortex or pipetting.

Stock: -80 °C

Stockage commentaire: Store at < -20°C, stable for 6 months after receipt.
Please minimize freeze-thaw cycles.

Date de péremption: 6 months

Détail du antigène

Antigène: PSG9 (Pregnancy Specific beta-1-Glycoprotein 9 (PSG9))

Autre désignation: PSG9 (PSG9 Produits)

Synonymes: PS34 Protein, PSG11 Protein, PSGII Protein, PSBG-9 Protein, PSBG-11 Protein, pregnancy specific beta-1-glycoprotein 9 Protein, PSG9 Protein

Sub Type: Fusionprotein

Sujet: Pregnancy-specific beta-1-glycoprotein 9(PSG9) is a secreted protein and contains 3 Ig-like C2-type (immunoglobulin-like) domains, 1 Ig-like V-type (immunoglobulin-like) domain. It is a member of the PSG family, a group of closely related secreted glycoproteins that are highly expressed in fetal placental syncytiotrophoblast cells. The members of the PSG protein family all have a characteristic N-terminal domain that is homologous to the immunoglobulin variable region. PSGs become detectable in serum during the first two to three weeks of pregnancy and increase as the pregnancy progresses, eventually representing the most abundant fetal protein in the maternal blood at term. PSGs function to stimulate secretion of TH2-type cytokines from monocytes, and they may also modulate the maternal immune system during pregnancy, thereby protecting the semi-allotypic fetus from rejection. PSGs are commonly expressed in trophoblast tumors. Eleven human PSG proteins (PSG1-PSG11) have been described.
Alternative Names: Pregnancy-specific beta-1-glycoprotein 9, PS-beta-G-9, PSBG-9, Pregnancy-specific glycoprotein 9, PS34, Pregnancy-specific beta-1 glycoprotein B, PS-beta-B, Pregnancy-specific beta-1-glycoprotein 11, PS-beta-G-11, PSBG-11, Pregnancy-specific glycoprotein

Poids moléculaire: 45.6 kDa

UniProt: Q00887